EUVIMEDAtklāt EUVIMED
Open access · CC BY-NC-ND 4.0

Challenges and opportunities for proton therapy during pregnancy

Jeroen Blommaert, Marijke De Saint-Hubert, Tom Depuydt, Edwin Oldehinkel, Philip Poortmans, Frederic Amant, Maarten Lambrecht

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14645 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2024. Written by Jeroen Blommaert and 6 co-authors. Institution: Department of Oncology, KU Leuven, Leuven, Belgium. Major MEDLINE topics: Proton Therapy. Cited 19 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

During pregnancy, the use of radiation therapy for cancer treatment is often considered impossible due to the assumed associated fetal risks. However, suboptimal treatment of pregnant cancer patients and unjustifiable delay in radiation therapy until after delivery can be harmful for both patient and child. In non‐pregnant patients, proton‐radiation therapy is increasingly administered because of its favorable dosimetric properties compared with photon‐radiation therapy. Although data on the use of pencil beam scanning proton‐radiation therapy during pregnancy are scarce, different case reports and dosimetric studies have indicated a more than 10‐fold reduction in fetal radiation exposure compared with photon‐radiation therapy. Nonetheless, the implementation of proton‐radiation therapy during pregnancy requires complex fetal dosimetry for the neutron‐dominated out‐of‐field radiation dose and faces a lack of clinical guidelines. Further exploration and standardization of proton‐radiation therapy during pregnancy will be necessary to improve radiotherapeutic management of pregnant women with cancer and further reduce risks for their offspring.

Subjects

MeSH terms (MEDLINE)

Proton TherapyFemaleHumansPregnancyFetusNeutronsProtonsRadiometryRadiotherapy Dosage

Author keywords

cancerfetal radiationpregnancyproton therapyradiation therapy

Substances

Protons

Authors and institutions

  • Department of Oncology, KU Leuven, Leuven, Belgium.
  • Belgium Nuclear Research Center, Mol, Belgium.
  • Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Radiation Oncology, Iridium Netwerk & University of Antwerp, Wilrijk, Belgium.
  • Gynecologic Oncology, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Cite

APA

Blommaert, J., De Saint-Hubert, M., Depuydt, T., Oldehinkel, E., Poortmans, P., Amant, F., & Lambrecht, M. (2024). Challenges and opportunities for proton therapy during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14645

Vancouver

Blommaert J, De Saint-Hubert M, Depuydt T, Oldehinkel E, Poortmans P, Amant F, et al. Challenges and opportunities for proton therapy during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14645

BibTeX
@article{Blommaert2024,
  author = {Blommaert, Jeroen and De Saint-Hubert, Marijke and Depuydt, Tom and Oldehinkel, Edwin and Poortmans, Philip and Amant, Frederic and Lambrecht, Maarten},
  title = {Challenges and opportunities for proton therapy during pregnancy},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14645}
}
Start for free →